Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Cross-referencing NIH grants against published research and clinical trials to identify funding-evidence gaps for Myoclonic Epilepsy. Strongest funded area: Basic Science. Largest gap: Biomarker / Diagnostics.
Clinical ResearchTrials Active, No NIH Grants
1 clinical trial registered but no NIH-funded clinical or translational research grants found for myoclonic epilepsy. Trials may be industry-sponsored or funded through non-NIH sources.
Biomarker / DiagnosticsPublished, Not NIH-Funded
10 publications in Diagnostic / Biomarker but no NIH-funded grants found in Biomarker / Diagnostics for myoclonic epilepsy. Existing research activity suggests this may be a viable area for grant applications.
Clinical ResearchPublished, Not NIH-Funded
5 publications in Clinical Trial Publication but no NIH-funded grants found in Clinical Research for myoclonic epilepsy. Existing research activity suggests this may be a viable area for grant applications.
Adjacent Research(2 grants)
These grants mention Myoclonic Epilepsy as part of broader research but are not primarily focused on this disease. They are not included in the funding totals above.
Other(2)
OtherR01Active
Function of sphingoid bases in brain health and disease
Spassieva, Stefanka·UNIVERSITY OF KENTUCKY·LEXINGTON, KY
